Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000006

GENERAL COUNSEL & CORP SEC sold 8,895 shares at an average $32.14 ($285,901)

From the SEC's structured data for this filing

Trades in this filing

Allan Jonathan · GENERAL COUNSEL & CORP SEC

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Sale : show line 1 in the form −2,476 $32.74 $81,063 35,255 D
2026-03-17 Sale : show line 2 in the form −1,791 $33.38 $59,775 33,464 D
2026-03-18 Sale : show line 3 in the form −4,222 $31.28 $132,080 29,242 D
2026-03-18 Sale : show line 4 in the form −334 $31.79 $10,617 28,908 D
2026-03-18 Sale : show line 5 in the form −72 $32.85 $2,365 28,836 D
Open-market sales · 8,895 sh · avg $32.14 · $285,901
Loading xslF345X06/form4-03192026_090304.xml…